FDA Approves OTC Combination Pill of Acetaminophen and Naproxen by Kenvue
The U.S. Food and Drug Administration (FDA) has approved a new over-the-counter combination pill developed by Kenvue, containing acetaminophen and naproxen sodium for pain relief. The product includes 325 mg of Tylenol (acetaminophen) and 110 mg of naproxen sodium in each dose, offering up to 12 hours of effect. This is the first FDA-approved combination pill that merges these two widely used analgesics into a single formulation. The approval marks an innovation for over-the-counter pain management options available to consumers without requiring a prescription.
Tickers: $KVUE
Topics: Kenvue OTC drugs pharmaceuticals